Generate Biomedicines, Inc. Common Stock (GENB) — Net Asset Quality Index
Generate Biomedicines, Inc. Common Stock (GENB) has a Net Asset Quality Index of -188.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $330.18 Million minus total liabilities of $953.38 Million yields net assets of $-623.20 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check GENB cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Generate Biomedicines, Inc. Common Stock Net Asset Quality Index Over Time (2024–2025)
This chart shows how Generate Biomedicines, Inc. Common Stock's Net Asset Quality Index has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the index stands at -188.7%, representing net assets of $-623.20 Million against total assets of $330.18 Million USD. See Generate Biomedicines, Inc. Common Stock current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Generate Biomedicines, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Net Asset Quality Index for Generate Biomedicines, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Generate Biomedicines, Inc. Common Stock.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -188.7% | $-623.20 Million | $330.18 Million | $953.38 Million | ▼ -104.8 pp |
| 2024 | -84.0% | $-435.09 Million | $518.26 Million | $953.35 Million | — |